ESC Professional Premium Access

CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.

Congress Session

About the speaker

Doctor Ju-Hee Lee

Chong Kun Dang Pharm., Yongin (Korea (Republic of))
1 presentation
0 follower

3 more presentations in this session

Ventricular Arrhythmic Risk Prediction in Low- and Moderate-risk Populations Using a Single-Lead ECG Heartbeat.

Speaker: Doctor J. Ramirez (Zaragoza, ES)

Thumbnail

The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Speaker: Assistant Professor G. Claessen (Leuven, BE)

Thumbnail

Precision approaches to defining susceptibility to atrial fibrillation determine risk of cardioembolic stroke.

Speaker: Doctor P. Gajendragadkar (Oxford, GB)

Thumbnail

Access the full session

Basic and Translational Late-Breaking Science 2

Speakers: Doctor J. Lee, Doctor J. Ramirez, Assistant Professor G. Claessen, Doctor P. Gajendragadkar
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk